BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1827227)

  • 1. Independent transformation activity by adenovirus-5 E1A-conserved regions 1 or 2 mutants.
    Svensson C; Bondesson M; Nyberg E; Linder S; Jones N; Akusjärvi G
    Virology; 1991 Jun; 182(2):553-61. PubMed ID: 1827227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional importance of complex formation between the retinoblastoma tumor suppressor family and adenovirus E1A proteins as determined by mutational analysis of E1A conserved region 2.
    Corbeil HB; Branton PE
    J Virol; 1994 Oct; 68(10):6697-709. PubMed ID: 8084002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cells.
    Rumpf H; Esche H; Kirch HC
    Virology; 1999 Apr; 257(1):45-53. PubMed ID: 10208919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular targets for transformation by the adenovirus E1A proteins.
    Whyte P; Williamson NM; Harlow E
    Cell; 1989 Jan; 56(1):67-75. PubMed ID: 2521301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis.
    Howe JA; Mymryk JS; Egan C; Branton PE; Bayley ST
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5883-7. PubMed ID: 2143024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.
    Wong HK; Ziff EB
    J Virol; 1996 Jan; 70(1):332-40. PubMed ID: 8523545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis.
    Shisler J; Duerksen-Hughes P; Hermiston TM; Wold WS; Gooding LR
    J Virol; 1996 Jan; 70(1):68-77. PubMed ID: 8523594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigen.
    Jelsma TN; Howe JA; Mymryk JS; Evelegh CM; Cunniff NF; Bayley ST
    Virology; 1989 Jul; 171(1):120-30. PubMed ID: 2568030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells.
    Duerksen-Hughes PJ; Hermiston TW; Wold WS; Gooding LR
    J Virol; 1991 Mar; 65(3):1236-44. PubMed ID: 1825340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of insertion mutants in E1A of adenovirus type 5.
    Bautista DS; Hitt M; McGrory J; Graham FL
    Virology; 1991 Jun; 182(2):578-96. PubMed ID: 1827228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interactions within adenovirus E1A protein complexes.
    Barbeau D; Charbonneau R; Whalen SG; Bayley ST; Branton PE
    Oncogene; 1994 Feb; 9(2):359-73. PubMed ID: 8290250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus E1A-p105(Rb) protein interactions play a direct role in the initiation but not the maintenance of the rodent cell transformed phenotype.
    Nielsch U; Fognani C; Babiss LE
    Oncogene; 1991 Jun; 6(6):1031-6. PubMed ID: 2067843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107.
    Zerfass K; Spitkovsky D; Schulze A; Joswig S; Henglein B; Jansen-Dürr P
    J Virol; 1996 Apr; 70(4):2637-42. PubMed ID: 8642699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    Lukas J; Müller H; Bartkova J; Spitkovsky D; Kjerulff AA; Jansen-Dürr P; Strauss M; Bartek J
    J Cell Biol; 1994 May; 125(3):625-38. PubMed ID: 8175885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation.
    Ames RS; Holskin B; Mitcho M; Shalloway D; Chen MJ
    J Virol; 1990 Sep; 64(9):4115-22. PubMed ID: 2143540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity.
    Stein RW; Corrigan M; Yaciuk P; Whelan J; Moran E
    J Virol; 1990 Sep; 64(9):4421-7. PubMed ID: 2143544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL; Rand A; Kelm RJ; Getz MJ
    Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A.
    Howe JA; Bayley ST
    Virology; 1992 Jan; 186(1):15-24. PubMed ID: 1530776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus.
    Dyson N; Buchkovich K; Whyte P; Harlow E
    Cell; 1989 Jul; 58(2):249-55. PubMed ID: 2546678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of transforming growth factor beta 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins.
    Missero C; Filvaroff E; Dotto GP
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3489-93. PubMed ID: 1673033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.